XC
ONC

XY Capital’s BeOne Medicines Ltd ONC Stock Holding History

XY Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,507
Closed -$1.19M – 315
2025
Q3 		$1.19M Buy
3,507
+1,199
+52% +$364K 0.63% 42
2025
Q2 		$559K Sell
2,308
-58,107
-96% -$14.3M 0.38% 27
2025
Q1 		$16.4M Buy
60,415
+35,812
+146% +$8.37M 4.67% 4
2024
Q4 		$4.54M Sell
24,603
-5,861
-19% -$1.2M 2.19% 9
2024
Q3 		$6.84M Buy
+30,464
New +$5.48M 2.34% 8
2024
Q2 		– Sell
-29,616
Closed -$4.63M – 102
2024
Q1 		$4.63M Buy
+29,616
New +$4.77M 2.07% 13
2023
Q4 		– Sell
-15,416
Closed -$2.77M – 144
2023
Q3 		$2.77M Buy
15,416
+14,235
+1,205% +$2.82M 1.59% 16
2023
Q2 		$211K Sell
1,181
-8,496
-88% -$1.96M 0.15% 91
2023
Q1 		$2.09M Buy
9,677
+4,659
+93% +$1.12M 0.81% 40
2022
Q4 		$1.1M Buy
+5,018
New +$920K 0.72% 28

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

XY Capital's ONC Position: Q4 2025 in Review

XY Capital sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 3,507 shares — an estimated $1.19M sold.

XY Capital first reported a position in ONC in Q4 2022 and held it in 10 quarters. The position peaked at $16.4M in Q1 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • XY Capital reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • XY Capital sold 3,507 BeOne Medicines Ltd shares in Q4 2025, an estimated $1.19M.
  • XY Capital first reported a position in BeOne Medicines Ltd in Q4 2022 and held it in 10 quarters.
  • XY Capital's BeOne Medicines Ltd position peaked at $16.4M in Q1 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on XY Capital's 13F filing for Q4 2025, filed 12 Feb 2026.